|
시장보고서
상품코드
1402891
디지털 PCR 및 정량적 PCR 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2031년)Digital PCR and Quantitative PCR Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 |
||||||
디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장 - 보고서 범위
세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장에 대한 TMR의 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻을 수 있는 기회를 연구하고 있습니다. 이 보고서는 2023년을 기준 연도로, 2031년을 예측 연도로 삼아 2017년부터 2031년까지 전 세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장의 수익을 제공합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장의 복합 연간 성장률(CAGR %)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 대부분의 조사 활동은 애널리스트가 주요 오피니언 리더, 업계 리더 및 오피니언 메이커를 인터뷰하는 방식으로 이루어졌습니다. 2차 조사에는 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장을 이해하기 위해 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조가 포함됩니다.
| 시장 스냅샷 | |
|---|---|
| 2023년 시장 가치 | 43억 달러 |
| 2031년 시장 가치 | 75억 달러 |
| CAGR | 6.3% |
이 보고서는 세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장의 경쟁 구도를 자세히 분석합니다. 세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장에서 활동하는 주요 기업이 확인되었으며, 이들 각각은 다양한 속성 측면에서 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 디지털 PCR(dPCR) 및 정량적 PCR(qPCR) 시장의 기업 속성입니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
- 서론
- 개요
- 시장 역학
- 세계 시장 분석과 예측, 2023-2031년
제5장 중요한 인사이트
- 지속적인 케어와 환자 관리의 실시간 PCR 응용
- dPCR와 qPCR 강점
- 주요 제품/브랜드 분석
- 기술 진보
- 시장 분야에서 활동하고 있는 주요 3개사
- 신종 코로나바이러스의 영향 분석
제6장 세계 시장 분석과 예측 : 제품 유형별
- 서론과 정의
- 주요 발견과 개발
- 시장 금액 예측 : 제품 유형별, 2023-2031년
- 정량적 PCR
- 시약과 소모품
- 기기
- 소프트웨어
- 디지털 PCR
- 시약과 소모품
- 기기
- 소프트웨어
- 정량적 PCR
- 시장 매력도 분석 : 제품 유형별
제7장 세계 시장 분석과 예측 : 용도별
- 서론과 정의
- 주요 발견과 개발
- 시장 금액 예측 : 용도별, 2023-2031년
- 임상 응용
- 조사 용도
- 병원체 검사
- 종양학 검사
- 혈액 검사
- 기타
- 시장 매력 분석 : 용도별
제8장 세계 시장 분석과 예측 : 최종사용자별
- 서론과 정의
- 주요 발견과 개발
- 시장 금액 예측 : 최종사용자별, 2023-2031년
- 병원과 진단 센터
- 연구·학술기관
- 제약·바이오테크놀러지 기업
- 임상 조사기관
- 기타
- 시장 매력도 분석 : 최종사용자별
제9장 세계 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력도 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 상황
- 시장 기업 - 경쟁 매트릭스(기업 계층 및 규모별)
- 시장 점유율 분석 : 기업별(2021년)
- 기업 개요
- Bio Rad Laboratories
- Thermo Fisher Scientific, Inc.
- Qiagen
- F. Hoffmann La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies
- BD
- Danaher Corporation
- Merck KGaA
- Takara Bio, Inc.
Digital PCR (dPCR) and Quantitative PCR (qPCR) Market - Scope of Report
TMR's report on the global digital PCR (dPCR) and quantitative PCR (qPCR) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global digital PCR (dPCR) and quantitative PCR (qPCR) market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital PCR (dPCR) and quantitative PCR (qPCR) market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital PCR (dPCR) and quantitative PCR (qPCR) market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 4.3 Bn |
| Market Value in 2031 | US$ 7.5 Bn |
| CAGR | 6.3% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital PCR (dPCR) and quantitative PCR (qPCR) market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital PCR (dPCR) and quantitative PCR (qPCR) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital PCR (dPCR) and quantitative PCR (qPCR) market.
The report delves into the competitive landscape of the global digital PCR (dPCR) and quantitative PCR (qPCR) market. Key players operating in the global digital PCR (dPCR) and quantitative PCR (qPCR) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital PCR (dPCR) and quantitative PCR (qPCR) market profiled in this report.
Key Questions Answered in Global digital PCR (dPCR) and quantitative PCR (qPCR) Market Report:
- What is the sales/revenue generated by digital PCR (dPCR) and quantitative PCR (qPCR) across all regions during the forecast period?
- What are the opportunities in the global digital PCR (dPCR) and quantitative PCR (qPCR) market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Digital PCR (dPCR) and Quantitative PCR (qPCR) Market - Research Objectives and Research Approach
The comprehensive report on the global digital PCR (dPCR) and quantitative PCR (qPCR) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global digital PCR (dPCR) and quantitative PCR (qPCR) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital PCR (dPCR) and quantitative PCR (qPCR) market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, 2023-2031
5. Key Insights
- 5.1. Applications of real-time PCR in the continuum of care and patient management.
- 5.2. Strengths of dPCR and qPCR
- 5.3. Key product/brand Analysis
- 5.4. Technological Advancements
- 5.5. Top 3 players operating in the market space
- 5.6. COVID Impact Analysis
6. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2023-2031
- 6.3.1. Quantitative PCR
- 6.3.1.1. Reagents & Consumables
- 6.3.1.2. Instruments
- 6.3.1.3. Software
- 6.3.2. Digital PCR
- 6.3.2.1. Reagents & Consumables
- 6.3.2.2. Instruments
- 6.3.2.3. Software
- 6.3.1. Quantitative PCR
- 6.4. Market Attractiveness Analysis, by Product Type
7. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2023-2031
- 7.3.1. Clinical Applications
- 7.3.2. Research Applications
- 7.3.3. Pathogen Testing
- 7.3.4. Oncology Testing
- 7.3.5. Blood Screening
- 7.3.6. Others
- 7.4. Market Attractiveness Analysis, by Application
8. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2023-2031
- 8.3.1. Hospitals & Diagnostic Centers
- 8.3.2. Research Laboratories & Academic Institutes
- 8.3.3. Pharmaceutical & Biotechnology Companies
- 8.3.4. Clinical Research Organizations
- 8.3.5. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product Type, 2023-2031
- 10.2.1. Quantitative PCR
- 10.2.1.1. Reagents & Consumables
- 10.2.1.2. Instruments
- 10.2.1.3. Software
- 10.2.2. Digital PCR
- 10.2.2.1. Reagents & Consumables
- 10.2.2.2. Instruments
- 10.2.2.3. Software
- 10.2.1. Quantitative PCR
- 10.3. Market Value Forecast, by Application, 2023-2031
- 10.3.1. Clinical Applications
- 10.3.2. Research Applications
- 10.3.3. Pathogen Testing
- 10.3.4. Oncology Testing
- 10.3.5. Blood Screening
- 10.3.6. Others
- 10.4. Market Value Forecast, by End-user, 2023-2031
- 10.4.1. Hospitals & Diagnostic Centers
- 10.4.2. Research Laboratories & Academic Institutes
- 10.4.3. Pharmaceutical & Biotechnology Companies
- 10.4.4. Clinical Research Organizations
- 10.4.5. Others
- 10.5. Market Value Forecast, by Country, 2023-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product Type, 2023-2031
- 11.2.1. Quantitative PCR
- 11.2.1.1. Reagents & Consumables
- 11.2.1.2. Instruments
- 11.2.1.3. Software
- 11.2.2. Digital PCR
- 11.2.2.1. Reagents & Consumables
- 11.2.2.2. Instruments
- 11.2.2.3. Software
- 11.2.1. Quantitative PCR
- 11.3. Market Value Forecast, by Application, 2023-2031
- 11.3.1. Clinical Applications
- 11.3.2. Research Applications
- 11.3.3. Pathogen Testing
- 11.3.4. Oncology Testing
- 11.3.5. Blood Screening
- 11.3.6. Others
- 11.4. Market Value Forecast, by End-user, 2023-2031
- 11.4.1. Hospitals & Diagnostic Centers
- 11.4.2. Research Laboratories & Academic Institutes
- 11.4.3. Pharmaceutical & Biotechnology Companies
- 11.4.4. Clinical Research Organizations
- 11.4.5. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product Type, 2023-2031
- 12.2.1. Quantitative PCR
- 12.2.1.1. Reagents & Consumables
- 12.2.1.2. Instruments
- 12.2.1.3. Software
- 12.2.2. Digital PCR
- 12.2.2.1. Reagents & Consumables
- 12.2.2.2. Instruments
- 12.2.2.3. Software
- 12.2.1. Quantitative PCR
- 12.3. Market Value Forecast, by Application, 2023-2031
- 12.3.1. Clinical Applications
- 12.3.2. Research Applications
- 12.3.3. Pathogen Testing
- 12.3.4. Oncology Testing
- 12.3.5. Blood Screening
- 12.3.6. Others
- 12.4. Market Value Forecast, by End-user, 2023-2031
- 12.4.1. Hospitals & Diagnostic Centers
- 12.4.2. Research Laboratories & Academic Institutes
- 12.4.3. Pharmaceutical & Biotechnology Companies
- 12.4.4. Clinical Research Organizations
- 12.4.5. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 12.5.1. China
- 12.5.2. India
- 12.5.3. Japan
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product Type, 2023-2031
- 13.2.1. Quantitative PCR
- 13.2.1.1. Reagents & Consumables
- 13.2.1.2. Instruments
- 13.2.1.3. Software
- 13.2.2. Digital PCR
- 13.2.2.1. Reagents & Consumables
- 13.2.2.2. Instruments
- 13.2.2.3. Software
- 13.2.1. Quantitative PCR
- 13.3. Market Value Forecast, by Application, 2023-2031
- 13.3.1. Clinical Applications
- 13.3.2. Research Applications
- 13.3.3. Pathogen Testing
- 13.3.4. Oncology Testing
- 13.3.5. Blood Screening
- 13.3.6. Others
- 13.4. Market Value Forecast, by End-user, 2023-2031
- 13.4.1. Hospitals & Diagnostic Centers
- 13.4.2. Research Laboratories & Academic Institutes
- 13.4.3. Pharmaceutical & Biotechnology Companies
- 13.4.4. Clinical Research Organizations
- 13.4.5. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Digital PCR (dPCR) and Quantitative PCR (qPCR) Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product Type, 2023-2031
- 14.2.1. Quantitative PCR
- 14.2.1.1. Reagents & Consumables
- 14.2.1.2. Instruments
- 14.2.1.3. Software
- 14.2.2. Digital PCR
- 14.2.2.1. Reagents & Consumables
- 14.2.2.2. Instruments
- 14.2.2.3. Software
- 14.2.1. Quantitative PCR
- 14.3. Market Value Forecast, by Application, 2023-2031
- 14.3.1. Clinical Applications
- 14.3.2. Research Applications
- 14.3.3. Pathogen Testing
- 14.3.4. Oncology Testing
- 14.3.5. Blood Screening
- 14.3.6. Others
- 14.4. Market Value Forecast, by End-user, 2023-2031
- 14.4.1. Hospitals & Diagnostic Centers
- 14.4.2. Research Laboratories & Academic Institutes
- 14.4.3. Pharmaceutical & Biotechnology Companies
- 14.4.4. Clinical Research Organizations
- 14.4.5. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company (2021)
- 15.3. Company Profiles
- 15.3.1. Bio Rad Laboratories
- 15.3.1.1. Company Overview
- 15.3.1.2. Product Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. Thermo Fisher Scientific, Inc.
- 15.3.2.1. Company Overview
- 15.3.2.2. Product Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Qiagen
- 15.3.3.1. Company Overview
- 15.3.3.2. Product Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. F. Hoffmann La Roche Ltd.
- 15.3.4.1. Company Overview
- 15.3.4.2. Product Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. Abbott Laboratories
- 15.3.5.1. Company Overview
- 15.3.5.2. Product Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.5.5. Strategic Overview
- 15.3.6. Agilent Technologies
- 15.3.6.1. Company Overview
- 15.3.6.2. Product Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.6.5. Strategic Overview
- 15.3.7. BD
- 15.3.7.1. Company Overview
- 15.3.7.2. Product Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.7.5. Strategic Overview
- 15.3.8. Danaher Corporation
- 15.3.8.1. Company Overview
- 15.3.8.2. Product Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.8.5. Strategic Overview
- 15.3.9. Merck KGaA
- 15.3.9.1. Company Overview
- 15.3.9.2. Product Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.9.5. Strategic Overview
- 15.3.10. Takara Bio, Inc.
- 15.3.10.1. Company Overview
- 15.3.10.2. Product Portfolio
- 15.3.10.3. Financial Overview
- 15.3.10.4. SWOT Analysis
- 15.3.10.5. Strategic Overview
- 15.3.1. Bio Rad Laboratories
